alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
118TH CONGRESS 

2D SESSION H. R. 7224 

AN ACT 

To amend the Public Health Service Act to reauthorize the 

Stop, Observe, Ask, and Respond to Health and Wellness 

Training Program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 7224 EH

1 SECTION 1. REAUTHORIZATION OF THE SOAR TO HEALTH 

2 AND WELLNESS TRAINING PROGRAM. 

3 Section 1254(h) of the Public Health Service Act (42 

4 U.S.C. 300d–54(h)) is amended by striking ‘‘fiscal years 

5 2020 through 2024’’ and inserting ‘‘fiscal years 2025 

6 through 2029’’. 

Passed the House of Representatives December 16, 

2024. 

Attest: 

Clerk. 

118TH CONGRESS 

2D SESSION H. R. 7224 

AN ACT 

To amend the Public Health Service Act to reauHealth and Wellness Training Program. thorize the Stop, Observe, Ask, and Respond to
# C_2014292EN.01006301.xml

| 1.9.2014 | EN | Official Journal of the European Union | C 292/63 |
| --- | --- | --- | --- |

1.9.2014

EN

Official Journal of the European Union

C 292/63

---

Action brought on 23 June 2014 — ZZ v EMA

(Case F-58/14)

2014/C 292/82

Language of the case: English

Parties

Parties

Applicant: ZZ (represented by: S. Rodrigues, lawyer)

Applicant:

Defendant: European Medicines Agency (EMA)

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the decision of the EMA not to renew the applicant’s contract of employment as temporary agent and compensation for the alleged damage suffered.

Form of order sought

Form of order sought

| — | Annul the decision of the EMA of 12 September 2013 not to renew the applicant’s contract of employment; |
| --- | --- |

—

Annul the decision of the EMA of 12 September 2013 not to renew the applicant’s contract of employment;

| — | Together with, and so far as necessary, the EMA’s decision dated 13 March 2014, rejecting the applicant’s complaint dated 19 November 2013 against the aforementioned decision; |
| --- | --- |

—

Together with, and so far as necessary, the EMA’s decision dated 13 March 2014, rejecting the applicant’s complaint dated 19 November 2013 against the aforementioned decision;

| — | Repair the material prejudice suffered by the applicant; |
| --- | --- |

—

Repair the material prejudice suffered by the applicant;

| — | Repair the moral prejudice suffered by the applicant, estimated at EUR 20  000; |
| --- | --- |

—

Repair the moral prejudice suffered by the applicant, estimated at EUR 20  000;

| — | Order the EMA to pay all the costs incurred by the applicant for the present appeal. |
| --- | --- |

—

Order the EMA to pay all the costs incurred by the applicant for the present appeal.

---
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-28-1998
<CASH>                                           1,170
<SECURITIES>                                         0
<RECEIVABLES>                                    2,250
<ALLOWANCES>                                       333
<INVENTORY>                                      9,548
<CURRENT-ASSETS>                                17,454
<PP&E>                                          22,562
<DEPRECIATION>                                  10,615
<TOTAL-ASSETS>                                  30,743
<CURRENT-LIABILITIES>                            8,584
<BONDS>                                          4,753
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            41
<OTHER-SE>                                      17,019
<TOTAL-LIABILITY-AND-EQUITY>                    30,743
<SALES>                                         17,122
<TOTAL-REVENUES>                                17,122
<CGS>                                           14,616
<TOTAL-COSTS>                                   14,616
<OTHER-EXPENSES>                                 4,465
<LOSS-PROVISION>                                    47
<INTEREST-EXPENSE>                                 170
<INCOME-PRETAX>                                (1,762)
<INCOME-TAX>                                       601
<INCOME-CONTINUING>                            (1,161)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,161)
<EPS-PRIMARY>                                    (.28)
<EPS-DILUTED>                                    (.28)
        

</TABLE>
Editorial Note on Part 201
Editorial Note: Nomenclature changes to part 201 appear at 69 FR 13717, Mar. 24, 2004.

§ 201.317 Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning. ( a ) Digitalis and related cardiotonic drugs for human use in oral dosage forms have been promoted for, and continue to be dispensed and prescribed for, use in the treatment of obesity, although their safety and effectiveness for that use have never been established.
( b ) Digitalis and related cardiotonic drugs for human use in oral dosage forms are misbranded within the meaning of section 502 of the Federal Food, Drug, and Cosmetic Act unless their labeling bears the following boxed warning at the beginning of the “Warnings” section: Digitalis alone or with other drugs has been used in the treatment of obesity. This use of digoxin or other digitalis glycosides is unwarranted. Moreover, since they may cause potentially fatal arrhythmias or other adverse effects, the use of these drugs in the treatment of obesity is dangerous.
( c ) This section does not apply to digoxin products for oral use.
[43 FR 22009, May 23, 1978, as amended at 85 FR 72907, Nov. 16, 2020]
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 03-1327

MICHAEL A. SCOTT; TERRY SCOTT,

Plaintiffs - Appellants,

versus

WELLS FARGO & COMPANY; WELLS FARGO HOME

MORTGAGE, INCORPORATED; GENERAL ELECTRIC

COMPANY; GE CAPITAL MORTGAGE SERVICES,

INCORPORATED,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern

District of Virginia, at Norfolk. Raymond A. Jackson, District

Judge. (CA-02-789-2)

Submitted: May 8, 2003 Decided: June 27, 2003

Before WIDENER, NIEMEYER, and MICHAEL, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Michael A. Scott, Terry Scott, Appellants Pro Se. Stanley Graves

Barr, Jr., KAUFMAN & CANOLES, Norfolk, Virginia, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Michael and Terry Scott appeal the district court’s judgment

granting partial summary judgment to the Appellees and dismissing

their complaint. We have reviewed the record and find no reversible

error. Accordingly, we affirm in part for the reasons stated by

the district court. See Scott v. Wells Fargo & Co., No. 02-789-2

(E.D. Va., filed Jan. 14, 2003, entered Jan. 15, 2003). Although

the Scotts may have been entitled to amend the complaint as of

right, see Fed. R. Civ. P. 15(a), we have reviewed the additional

claims raised in the proposed amended complaint and find the

amendment futile. We also deny the Scotts’ motions for summary

reversal and an injunction. We dispense with oral argument because

the facts and legal contentions are adequately presented in the

materials before the court and argument would not aid the

decisional process.

AFFIRMED
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(Chief Executive Officer)

In connection with the Quarterly Report of CEC Entertainment, Inc. (the Company) on Form
10-Q for the quarter ended September 28, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned certifies that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                 |  |                        
|---------------- |  | -----------------------
|November 7, 2008 |  | /s/ Richard M. Frank   
|                 |  | Richard M. Frank       
|                 |  | Chief Executive Officer
# C_2014448EN.01004001.xml

| 15.12.2014 | EN | Official Journal of the European Union | C 448/40 |
| --- | --- | --- | --- |

15.12.2014

EN

Official Journal of the European Union

C 448/40

---

Action brought on 10 September 2014 — ZZ v European Parliament

(Case F-92/14)

(2014/C 448/50)

Language of the case: German

Parties

Parties

Applicant: ZZ (represented by: Günther Maximini, lawyer)

Applicant:

Defendant: European Parliament

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Application, first, to annul the Parliament's decision in which the Parliament refused to take a preventative approach to the harm which the plaintiff has suffered due to infringements of his personal rights and of the provisions of Regulation No 45/2011 in the context of the treatment of a previous case, and, secondly, to award non-financial damages with interest for late payment for the non-financial harm which he allegedly suffered.

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the European Parliament’s decision of 5 March 2014 which rejected the applicant’s application of 16 December 2013 for damages, as well as the implied rejection of his complaint of 24 March 2014 against that decision, and, in the alternative, the subsequent decision of 29 July 2014 by an unknown author; |
| --- | --- |

—

Annul the European Parliament’s decision of 5 March 2014 which rejected the applicant’s application of 16 December 2013 for damages, as well as the implied rejection of his complaint of 24 March 2014 against that decision, and, in the alternative, the subsequent decision of 29 July 2014 by an unknown author;

| — | Order the defendant to pay the applicant EUR 30  000 for non-financial damages, together with interest for late payment at the rate of five percentage points above the base rate on EUR 25  000 from 1 February 2014 and on EUR 5  000 from 1 May 2014; |
| --- | --- |

—

Order the defendant to pay the applicant EUR 30  000 for non-financial damages, together with interest for late payment at the rate of five percentage points above the base rate on EUR 25  000 from 1 February 2014 and on EUR 5  000 from 1 May 2014;

| — | Order the defendant to pay the costs of the proceedings, including the pre-litigation procedure and all necessary expenses and costs incurred by the applicant. |
| --- | --- |

—

Order the defendant to pay the costs of the proceedings, including the pre-litigation procedure and all necessary expenses and costs incurred by the applicant.

---
EXHIBIT
32.2





CERTIFICATION
OF CHIEF FINANCIAL OFFICER





Pursuant
to Section 906 of the Sarbanes Oxley Act of 2002 (18 U.S.C. 1350)
and


Rule
13a-14(b) of the Securities Exchange Act of 1934




I,
Dominick Ragone, Chief Financial Officer of Icahn Enterprises G.P. Inc., the
general partner of Icahn Enterprises L.P. (the “Registrant”), certify that, to
the best of my knowledge, based upon a review of the Icahn Enterprises L.P.,
quarterly report on Form 10-Q/A for the period ended March 31, 2009 of the
Registrant (the “Report”):




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.




/s/
      Dominick RagoneDominick
      RagoneChief
      Financial Officer of Icahn Enterprises G.P. Inc.,
              the
      general partner of Icahn Enterprises L.P.


Date:
August 4, 2009
###### Editorial Note on Part 312

#### Editorial Note:

Nomenclature changes to part 312 appear at 69 FR 13717, Mar. 24, 2004.

#### § 312.61 Control of the investigational drug.

An investigator shall administer the drug only to subjects under the investigator's personal supervision or under the supervision of a subinvestigator responsible to the investigator. The investigator shall not supply the investigational drug to any person not authorized under this part to receive it.
§ 582.6033 Citric acid. ( a ) *Product.* Citric acid.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Footnotes -
582.6033
[2] For the purpose of this subpart, no attempt has been made to designate those sequestrants that may also function as chemical preservatives.
§ 582.5881 Threonine. ( a ) *Product.* Threonine (L- and DL-forms).
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

210 

KA 12-01242 

PRESENT: SMITH, J.P., FAHEY, CARNI, SCONIERS, AND VALENTINO, JJ. 

 

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT, 

V MEMORANDUM AND ORDER

MARCO A.C., DEFENDANT-APPELLANT. 

 

D.J. & J.A. CIRANDO, ESQS., SYRACUSE (BRADLEY E. KEEM OF COUNSEL), FOR

DEFENDANT-APPELLANT. 

JOSEPH V. CARDONE, DISTRICT ATTORNEY, ALBION (KATHERINE BOGAN OF

COUNSEL), FOR RESPONDENT. 

 

Appeal from an adjudication of the Orleans County Court (James P.

Punch, J.), rendered April 16, 2012. Defendant was adjudicated a

youthful offender upon his plea of guilty of attempted burglary in the

second degree. 

It is hereby ORDERED that the adjudication so appealed from is

unanimously affirmed.

Memorandum: Defendant appeals from a youthful offender

adjudication convicting him, upon his plea of guilty, of attempted

burglary in the second degree (Penal Law §§ 110.00, 140.25 [2]). 

Defendant’s contention regarding the voluntariness of his plea is not

preserved for our review because he did not move to withdraw his plea

or to vacate the adjudication on that ground (see People v Rosado, 70

AD3d 1315, 1315-1316, lv denied 14 NY3d 892). Contrary to defendant’s

contention, this case does not fall within the rare exception to the

preservation requirement because nothing in the plea allocution calls

into question the voluntariness of the plea or casts “significant

doubt” upon his guilt (People v Lopez, 71 NY2d 662, 666; see People v

Cubi, 104 AD3d 1225, 1226, lv denied 21 NY3d 1003).

Defendant failed to preserve for our review his contention that

County Court erred in ordering restitution without conducting a

hearing (see People v Robinson, 112 AD3d 1349, 1350; People v Baker,

57 AD3d 1500, 1500), and we decline to exercise our power to review

that contention as a matter of discretion in the interest of justice

(see CPL 470.15 [3] [c]). To the extent that defendant’s contention

that he was denied effective assistance of counsel survives his plea

of guilty (see People v Robinson, 39 AD3d 1266, 1267, lv denied 9 NY3d

869), we reject that contention. The record establishes that

defendant received “an advantageous plea and nothing in the record

casts doubt on the apparent effectiveness of counsel” (People v Ford,
-2- 210 

KA 12-01242 

86 NY2d 397, 404). 

Entered: March 21, 2014 Frances E. Cafarell

Clerk of the Court
**Exhibit 31.1**

 

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

 

I, Thomas J. Shaw, certify that: 

 

1. I have reviewed this annual report on Form 10-KSB of Retractable Technologies, Inc.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary tomake the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financialcondition, results of operations, and cash flows of the small business issuer as of, and for, the periods presented in this report; 

 

4. The small business issuer’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e) for the small business issuer and have: 

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including itsconsolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

b) Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; 

 

c) Disclosed in this report any changes in the small business issuer’s internal controls over financial reporting that occurred during the small businessissuer’s most recent fiscal quarter (the small business issuer’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal controlsover financial reporting; and 

 

5. The small business issuer’s othercertifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors(or persons performing the equivalent functions): 

 

a) All significantdeficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize, and report financialinformation; and 

 

b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the small business issuer’s internal controls over financial reporting. 

 

Date: March 31, 2005
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               SEP-27-1998
<CASH>                                          39,762
<SECURITIES>                                         0
<RECEIVABLES>                                  583,131
<ALLOWANCES>                                    47,838
<INVENTORY>                                    594,689
<CURRENT-ASSETS>                             1,207,454
<PP&E>                                         938,064
<DEPRECIATION>                                 363,381
<TOTAL-ASSETS>                               2,550,252
<CURRENT-LIABILITIES>                          593,488
<BONDS>                                      1,313,703
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           213
<OTHER-SE>                                     325,750
<TOTAL-LIABILITY-AND-EQUITY>                 2,550,252
<SALES>                                      1,145,668
<TOTAL-REVENUES>                             1,145,668
<CGS>                                          844,480
<TOTAL-COSTS>                                  844,480
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 7,068
<INTEREST-EXPENSE>                              53,455
<INCOME-PRETAX>                                  1,195
<INCOME-TAX>                                     5,167
<INCOME-CONTINUING>                            (3,770)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    301
<CHANGES>                                            0
<NET-INCOME>                                   (4,071)
<EPS-PRIMARY>                                   (0.19)
<EPS-DILUTED>                                   (0.19)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000813897
<NAME> PHS MASTER L.P.I
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       1,087,697
<SECURITIES>                                         0
<RECEIVABLES>                                1,062,459
<ALLOWANCES>                                         0
<INVENTORY>                                    107,290
<CURRENT-ASSETS>                             3,330,556
<PP&E>                                      59,218,287
<DEPRECIATION>                              23,850,112
<TOTAL-ASSETS>                              39,757,158
<CURRENT-LIABILITIES>                       47,768,818
<BONDS>                                        500,000
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 (8,511,660)
<TOTAL-LIABILITY-AND-EQUITY>                39,757,158
<SALES>                                     18,654,168
<TOTAL-REVENUES>                            18,704,825
<CGS>                                                0
<TOTAL-COSTS>                               14,644,427
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           3,557,937
<INCOME-PRETAX>                                502,461
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   502,461
<EPS-PRIMARY>                                      .16
<EPS-DILUTED>                                      .16
        

</TABLE>
<PAGE>   1




                                                                    EXHIBIT 23.3




March 30, 2000

To the Board of Directors of Forcenergy Inc:

We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (File Nos. 333-30524 and 333-32720) of Forcenergy Inc of
our reports dated January 28, 2000, February 26, 1999 and February 16, 1998,
and our estimates of the net proved natural gas and oil reserves of Forcenergy,
as of January 1, 2000, 1999 and 1998, and to all references to our estimates of
the net proved natural gas and oil reserves of the Company as of those dates,
included in this Annual Report on Form 10-K for the year ended December 31,
1999.

                                            COLLARINI ENGINEERING INC.



                                            /s/  Cheryl R. Collarini, P.E.
                                            --------------------------------
                                            Cheryl R. Collarini, P.E.
                                            President